Displaying 3 results of Tranylcypromine Impurities

Tranylcypromine is a monoamine oxidase inhibitor (MAOI) used for the treatment of depression. Tranylcypromine impurities are unwanted substances that may be present in the drug product. These impurities can affect the quality, safety, and efficacy of the drug. It is crucial to identify and control these impurities to ensure the drug's purity and effectiveness. The impurities may include degradation products, starting materials, and other related substances. Regulatory agencies require a thorough characterization and control of these impurities during the drug development process.